We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$1.95B
AUM Growth
+$108M
Cap. Flow
+$36.7M
Cap. Flow %
1.88%
Top 10 Hldgs %
38.39%
Holding
457
New
17
Increased
108
Reduced
186
Closed
24

Top Buys

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$33.9M
2
CNQ icon
Canadian Natural Resources
CNQ
+$5.27M
3
PXD
Pioneer Natural Resource Co.
PXD
+$4.97M
4
PAAS icon
Pan American Silver
PAAS
+$3.54M
5
OMER icon
Omeros
OMER
+$3.53M

Top Sells

Rank Stock Value
1
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$7.57M
2
INTC icon
Intel
INTC
+$951K
3
HXL icon
Hexcel
HXL
+$791K
4
NVEI
Nuvei Corporation Subordinate Voting Shares
NVEI
+$777K
5
MSFT icon
Microsoft
MSFT
+$687K

Sector Composition

Rank Sector Weight
1 Healthcare 21.25%
2 Energy 17.15%
3 Technology 13.62%
4 Financials 12.38%
5 Industrials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHPT icon
426
ChargePoint
CHPT
$141M
– –
-589
Closed -$112K
CNQ icon
427
PUT
Canadian Natural Resources
CNQ
$99.4B
– –
-27,800
Closed -$772K
IMAX icon
428
CALL
IMAX
IMAX
$2.62B
– –
-25,000
Closed -$557K
MET icon
429
MetLife
MET
$61.9B
– –
-3,360
Closed -$243K
CALY
430
Callaway Golf Company
CALY
$3.32B
– –
-10,039
Closed -$198K
NOC icon
431
Northrop Grumman
NOC
$77.1B
– –
-415
Closed -$226K
OIS icon
432
Oil States International
OIS
$489M
– –
-57,000
Closed -$425K
ORLA
433
DELISTED
Orla Mining
ORLA
– –
-118,763
Closed -$480K
PD icon
434
CALL
PagerDuty
PD
$816M
– –
-13,700
Closed -$364K
RIG icon
435
Transocean
RIG
$5.89B
– –
-30,500
Closed -$139K
TPL icon
436
Texas Pacific Land
TPL
$27.8B
– –
-1,890
Closed -$492K
TSCO icon
437
Tractor Supply
TSCO
$16.1B
– –
-5,000
Closed -$225K
UHS icon
438
Universal Health Services
UHS
$10.2B
– –
-1,500
Closed -$211K
UTG icon
439
Reaves Utility Income Fund
UTG
$3.54B
– –
-9,378
Closed -$265K
VRT icon
440
Vertiv
VRT
$93B
– –
-11,510
Closed -$157K
WBS icon
441
Webster Financial
WBS
$12.5B
– –
-4,556
Closed -$216K
XYL icon
442
Xylem
XYL
$27.3B
– –
-1,866
Closed -$206K
SMAR
443
CALL
DELISTED
Smartsheet Inc.
SMAR
– –
-18,600
Closed -$732K
CNCE
444
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-1,295,833
Closed -$7.57M
ATNX
445
DELISTED
Athenex, Inc. Common Stock
ATNX
– –
-500
Closed -$1K
HZNP
446
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-2,760
Closed -$314K
LUNA
447
DELISTED
Luna Innovations Incorporated
LUNA
– –
-10,961
Closed -$96K
14 15 16 17
18

Similar funds

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
GI
GLOBALT Investments Atlanta, Georgia $2.8B AUM 21.13% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
SHIM
Spruce House Investment Management New York $2.8B AUM 65.68% 1-Year Est. Return

Ingalls & Snyder LLC's Q1 2023 Portfolio in Review

As of Q1 2023, Ingalls & Snyder LLC held 457 positions worth $1.95B, up 5.9% from $1.84B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Ingalls & Snyder LLC's Q1 2023 filing shows 17 new, 108 increased, 186 reduced and 24 closed positions. Its largest new stake was TSMC: 31,331 shares worth $2.91M. The largest sale was Concert Pharmaceuticals, Inc., an estimated $7.57M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Energy and Technology.

  • Ingalls & Snyder LLC's largest Q1 2023 buy was TSMC: 31,331 shares worth $2.91M.
  • Ingalls & Snyder LLC added most to Corcept Therapeutics in Q1 2023, an estimated $33.9M increase.
  • Ingalls & Snyder LLC's biggest Q1 2023 reduction was Intel, cutting an estimated $951K.
  • Ingalls & Snyder LLC fully exited Concert Pharmaceuticals, Inc. in Q1 2023, selling an estimated $7.57M.
  • Ingalls & Snyder LLC's ten largest holdings make up 38% of its $1.95B portfolio in Q1 2023.
  • Ingalls & Snyder LLC opened 17 new positions and closed 24 in Q1 2023.
  • Ingalls & Snyder LLC's portfolio value rose 5.9% quarter-over-quarter to $1.95B.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2023, filed 9 May 2023.